OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency

Ads

You May Also Like

Allergy Partners Celebrates 25 Years

ASHEVILLE, N.C., Nov. 04, 2016 (GLOBE NEWSWIRE) -- This year marks the 25th Anniversary ...

Teladoc Expands Virtual Care Capabilities in Texas

LEWISVILLE, Texas, May 19, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC), the undisputed leader ...

Alpine Vision Announces Addition of Dr. Audrey Merryman to the Practice

COLORADO SPRINGS, Colo., March 20, 2016 (GLOBE NEWSWIRE) -- Alpine Vision announced that Dr. ...